Complement therapeutics
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference22 articles.
1. Complement in disease: a defence system turning offensive;Ricklin;Nat. Rev.: Nephrol.,2016
2. Complement: a key system for immune surveillance and homeostasis;Ricklin;Nat. Immunol.,2010
3. Complement, a target for therapy in inflammatory and degenerative diseases;Morgan;Nat. Rev. Drug Discov.,2015
4. New milestones ahead in complement-targeted therapy;Ricklin;Semin. Immunol.,2016
5. Paroxysmal nocturnal hemoglobinuria in the era of complement inhibition;Risitano;Am. J. Hematol.,2016
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Complement‐targeted therapeutics: An emerging field enabled by academic drug discovery;American Journal of Hematology;2023-03-31
2. Bispecific mAb2 Antibodies Targeting CD59 Enhance the Complement-Dependent Cytotoxicity Mediated by Rituximab;International Journal of Molecular Sciences;2022-05-06
3. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option;Journal of Immunology Research;2021-07-29
4. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials;Frontiers in Immunology;2021-07-06
5. Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist’s Opinion;Journal of Clinical Medicine;2020-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3